Researchers develop mathematical measures to better personalize therapy for prostate cancer

Дата публикации: 13-08-2026 12:20:01

Researchers at Moffitt Cancer Center have developed three mathematical biomarkers that may help physicians personalize adaptive therapy for prostate cancer by predicting treatment outcomes early in treatment. The biomarkers are specialized mathematical measures calculated from routine prostate-specific antigen (PSA) blood tests.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Precision therapy for metastatic prostate cancer improves survival	2	7	20-08-2024
2	New urine-based test detects high-grade prostate cancer, helping men avoid unnecessary biopsies	5	7	18-04-2024
3	Blood test distinguishes neuroendocrine subtype of advanced prostate cancer	0	8	10-01-2024
4	For early prostate cancer, 'active surveillance' is now the number 1 choice	0	9.98	13-08-2026
5	New antibody drug stops aggressive prostate cancer from spreading	0	6.72	21-07-2026
6	Scientists find a new weakness in treatment-resistant prostate cancer	0	10.8	08-09-2026
7	Half of prostate cancer focal therapy use found to fall outside current guideline-supported groups	0	7.2	13-08-2026
8	AI digital twin platform advances personalized cancer treatment planning	0	10.93	13-08-2026
9	Cancer-specific c-Myc mapping reveals overlooked SLK protein as treatment target	0	17.95	13-08-2026
10	Experimental treatment kills prostate tumor cells while reawakening antitumor immunity	0	8.19	15-06-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 7.4. Источник: medicalxpress.com.